Publication: Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
Loading...
Open/View Files
Date
2018
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Liu, X., S. Qin, Z. Wang, J. Xu, J. Xiong, Y. Bai, Z. Wang, et al. 2018. “Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study.” Journal of Hematology & Oncology 11 (1): 5. doi:10.1186/s13045-017-0545-5. http://dx.doi.org/10.1186/s13045-017-0545-5.
Abstract
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service